BioSpace News Archive

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced recent business highlights along with its financial results for the quarter ended September 30, 2022.

Viridian Therapeutics, Inc. today announced positive topline clinical data from the first two cohorts in its ongoing Phase 1/2 clinical trial of VRDN-001, an anti-IGF-1R antibody, in patients with active thyroid eye disease (TED).

Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder), a novel investigational therapeutic product candidate for the acute treatment of migraine, today reported topline results from the STS101 SUMMIT Phase 3 efficacy trial.

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced its financial and operating results for the third quarter ended September 30, 2022.

ProMIS Neurosciences Inc today announced its third quarter 2022 financial results and recent highlights.

Late in 2021, Aerogen® and CanSinoBIO announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia Air™ utilizing Aerogen’s proprietary aerosol drug delivery technology.

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide announced that the Therapeutic Goods Administration of Australia has granted marketing authorization to Cipla Australia Pty Ltd for Alvotech’s AVT02, a high-concentration low-volume biosimilar to Humira®.

Nanotronics is pleased to announce the opening of an office in Munich, Germany, led by Managing Director, Marius Fischer, who will report to Global CEO and cofounder, Dr. Matthew Putman.

Opiant Pharmaceuticals Inc. announced that it has entered into a definitive merger agreement to be acquired by Indivior Inc, a subsidiary of Indivior PLC.

BioArctic AB announced that the US Patent and Trademark Office has granted BioArctic a new platform patent for a technology for transporting biopharmaceuticals across the blood-brain barrier.